| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |